A. B. Schulze and L. H. Schmidt, PD-1 targeted Immunotherapy as first-line therapy for advanced nonsmall-cell lung cancer patients, J Thorac Dis, vol.9, pp.384-390, 2017.

J. V. Cohen, H. Tawbi, K. A. Margolin, R. Amravadi, M. Bosenberg et al., Melanoma central nervous system metastases: current approaches, challenges, and opportunities, Pigment Cell Melanoma Res, vol.29, pp.627-669, 2016.

J. L. Villano, E. B. Durbin, C. Normandeau, J. P. Thakkar, V. Moirangthem et al., Incidence of brain metastasis at initial presentation of lung cancer, Neuro-Oncol, vol.17, pp.122-130, 2015.

J. D. Zindler, G. Rodrigues, C. Haasbeek, P. F. De-haan, O. Meijer et al., The clinical utility of prognostic scoring systems in patients with brain metastases treated with radiosurgery, Radiother Oncol, vol.106, pp.370-374, 2013.

N. Kibbi and H. Kluger, The Treatment of Melanoma Brain Metastases, Curr Oncol Rep, vol.18, p.73, 2016.

R. Wiggenraad, A. V. Kanter, H. B. Kal, M. Taphoorn, T. Vissers et al., Dose-effect relation in stereotactic radiotherapy for brain metastases. A systematic review, Radiother Oncol, vol.98, pp.292-299, 2011.

Z. A. Seymour, S. E. Fogh, S. K. Westcott, S. Braunstein, D. A. Larson et al., Interval From Imaging to Treatment Delivery in the Radiation Surgery Age: How Long Is Too Long?, Int J Radiat Oncol, vol.93, pp.126-158, 2015.

M. Garcia, S. Duriseti, S. Fogh, J. Nakamura, D. Larson et al., RTRB-06 Time between diagnostic MRI and frame-fixed stereotactic radiosurgery planning MRI is associated with brain metastasis growth but not worse local control, Neuro-Oncol, vol.17, pp.196-196, 2015.

. Minniti, , 2011.

J. A. Miller, Int J Radiat Oncol Biol Phys, 2016.

O. Bohoudi, A. Bruynzeel, F. J. Lagerwaard, J. P. Cuijpers, B. J. Slotman et al., Isotoxic radiosurgery planning for brain metastases, Radiother Oncol, vol.120, pp.253-260, 2016.

G. Noël, J. M. Simon, C. Valery, P. Cornu, G. Boisserie et al., Radiosurgery for brain metastasis: impact of CTV on local control, Radiother Oncol, vol.68, p.207, 2003.

S. Goldberg, S. N. Gettinger, A. Mahajan, A. C. Chiang, R. S. Herbst et al., Pembrolizumab for patients with melanoma or non-small-cell lung cancer and untreated brain metastases: early analysis of a non-randomised, open-label, phase 2 trial, Lancet Oncol, vol.17, issue.7, p.976, 2016.

, Mis en forme : Normal, Interligne : simple Mis en forme : Police :Calibri